Results 121 to 130 of about 115,117 (314)

PRRT plus holmium‐166‐SIRT (HEPAR PLuS) versus PRRT‐only in patients with metastatic neuroendocrine tumors: A propensity‐score matched analysis

Journal of Neuroendocrinology, EarlyView.
Abstract Patients with bulky neuroendocrine liver metastases (NELM) undergoing PRRT with [177Lu]Lu‐DOTATATE have a worse survival than patients with limited liver metastases. Previously, the safety and efficacy of additional selective internal radiotherapy (SIRT), using holmium‐166 (166Ho)‐microspheres, directly following PRRT in patients with NELM ...
W. B. Veldhuis, T. Walter, D. M. V. de Vries‐Huizing, J. Theysohn, S. Barton, E. D. Ekkelenkamp, B. Lachachi, R. J. G. de Jong, L. W. van Golen, H. Lanzafame, L. Milot, H. Lahner, M. E. G. H. Lam, M. E. T. Tesselaar, A. J. A. T. Braat   +14 more
wiley   +1 more source

Effects of Somatostatin (SRIF) Infusion on Glucose Homeostasis in Newborn Lambs: Evidence for a Significant Role of Glucagon [PDF]

, 1977
Mark A. Sperling, Luiz A. Grajwer, Rosemary D. Leake, Delbert A. Fisher   +3 more
openalex   +1 more source

Pancreatic neuroendocrine tumors in children and adolescents—Data from the German MET studies (1997–2023)

Journal of Neuroendocrinology, EarlyView.
Abstract Pancreatic neuroendocrine tumors (panNETs) are rare pediatric malignancies with age‐specific clinical and biological features. Data on their presentation, management, and outcomes remain limited. This retrospective study analyzed 28 pediatric panNET cases from the German Malignant Endocrine Tumor (MET) Registry enrolled between 1997 and 2024 ...
Katharina Karges, Marina Kunstreich, Ulrich‐Frank Pape, Jörg Fuchs, Christian Vokuhl, Michael Abele, Dominik T. Schneider, Ines B. Brecht, Constantin Lapa, Michael C. Frühwald, Peter Vorwerk, Antje Redlich, Michaela Kuhlen   +12 more
wiley   +1 more source

The effect of somatostatin on the response of GLI to the intraduodenal administration of glucose, protein, and fat [PDF]

, 1975
Hideo Sakurai, Richard Dobbs, Roger H. Unger   +2 more
openalex   +1 more source

The impact of re‐characterizing metastatic pancreatic neuroendocrine tumors: A prospective study

Journal of Neuroendocrinology, EarlyView.
Abstract The biology of metastatic pancreatic neuroendocrine tumors (panNET) may alter over time. It remains to be defined if, how, and when this patient group should be recommended to re‐evaluate the characteristics of their disease. This prospective single‐center, longitudinal cohort study at Uppsala University Hospital, Sweden (NCT03130205 ...
Kazhan Mollazadegan, Johan Botling, Britt Skogseid, Barbro Eriksson, Lovisa Falkman, Liang Zhang, Ieva Lase, Staffan Welin, Anders Sundin, Joakim Crona   +9 more
wiley   +1 more source

Erratum to: Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F–DOPA

European Journal of Nuclear Medicine and Molecular Imaging, 2017
M. Bozkurt, I. Virgolini, S. Balogova, M. Beheshti, D. Rubello, C. Decristoforo, V. Ambrosini, A. Kjaer, R. Delgado-Bolton, J. Kunikowska, W. Oyen, A. Chiti, F. Giammarile, A. Sundin, S. Fanti   +14 more
semanticscholar   +1 more source

Fragility fractures in well‐differentiated gastroenteropancreatic neuroendocrine tumors: Results from a multicentered retrospective study

Journal of Neuroendocrinology, EarlyView.
Abstract Patients with gastroenteropancreatic–neuroendocrine tumors (GEP‐NETs) may present skeletal fragility that might be related to multiple factors, including bone metastases, vitamin D deficiency, hormone secretion, and disease treatments. This study examines the prevalence and determinants of fragility fractures in low grading (G1‐G2) GEP‐NETs ...
Alessandro Brunetti, Miriam Cellini, Elisabetta Lavezzi, Alessandro Zerbi, Giuseppe Ferrillo, Maria Francesca Birtolo, Alfredo Berruti, Guido Cavati, Marta Lagana, Luigi Gennari, Rossano Girometti, Chiara Zuiani, Franco Grimaldi, Andrea G. Lania, Fabio Vescini, Gherardo Mazziotti   +15 more
wiley   +1 more source

Somatostatin and cancer

Metabolism, 1996
The potential role of somatostatin (SRIF) in the diagnosis and treatment of nonendocrine human cancers is reviewed. There have been many reports of the growth-inhibitory activity of SRIF on normal and transformed cells in vitro. Many processes involved in malignant tumor growth depend on autocrine growth mechanisms, and somatostatin receptors (ssts ...
openaire   +3 more sources

Controversies in NEN: An ENETS position statement on the endoscopic management of localised gastric, duodenal and rectal neuroendocrine neoplasms

Journal of Neuroendocrinology, EarlyView.
Abstract Gastric, duodenal and rectal neuroendocrine tumours (NETs) are increasingly detected due to advances in endoscopic imaging. While international guidelines provide criteria for endoscopic management, several aspects remain controversial due to limited high‐quality evidence.
Francesco Panzuto, Dermot O'Toole, Günter Klöppel, Ulrich Peter Knigge, Günter Josef Krejs, Marina Tsoli, Marco Volante, Tu Vinh Luong   +7 more
wiley   +1 more source

The Ontogenesis of Human Fetal Hormones. IV. Somatostatin, Luteinizing Hormone Releasing Factor, and Thyrotropin Releasing Factor in Hypothalamus and Cerebral Cortex of Human Fetuses 10-22 Weeks of Age [PDF]

, 1977
Michel L. Aubert, Melvin M. Grumbach, Selna L. Kaplan   +2 more
openalex   +1 more source